GW PHARMACEUTICALS PLC's ticker is and the CUSIP is 36197T903. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $8,351,000 | -9.1% | 38,500 | -51.6% | 0.01% | -25.0% |
| Q4 2020 | $9,187,000 | +252.1% | 79,600 | +197.0% | 0.02% | +100.0% |
| Q3 2020 | $2,609,000 | -31.6% | 26,800 | -13.8% | 0.01% | -55.6% |
| Q2 2020 | $3,817,000 | -13.7% | 31,100 | -38.4% | 0.02% | -50.0% |
| Q1 2020 | $4,422,000 | -42.2% | 50,500 | -31.0% | 0.04% | -30.8% |
| Q4 2019 | $7,654,000 | -40.2% | 73,200 | -34.2% | 0.05% | -49.5% |
| Q3 2019 | $12,803,000 | +122.4% | 111,300 | +233.2% | 0.10% | +98.1% |
| Q2 2019 | $5,758,000 | +118.9% | 33,400 | +114.1% | 0.05% | +79.3% |
| Q1 2019 | $2,630,000 | -32.3% | 15,600 | -60.9% | 0.03% | -14.7% |
| Q4 2018 | $3,886,000 | -27.0% | 39,900 | +29.5% | 0.03% | -19.0% |
| Q3 2018 | $5,320,000 | +17.7% | 30,800 | -4.9% | 0.04% | +7.7% |
| Q2 2018 | $4,521,000 | +60.5% | 32,400 | +29.6% | 0.04% | +39.3% |
| Q1 2018 | $2,817,000 | -73.1% | 25,000 | -68.4% | 0.03% | -61.6% |
| Q4 2017 | $10,455,000 | +10.5% | 79,200 | -15.0% | 0.07% | -15.1% |
| Q3 2017 | $9,459,000 | +13.8% | 93,200 | +12.4% | 0.09% | 0.0% |
| Q2 2017 | $8,311,000 | -45.1% | 82,900 | -33.7% | 0.09% | -51.1% |
| Q1 2017 | $15,130,000 | -41.7% | 125,100 | -46.1% | 0.18% | -30.2% |
| Q4 2016 | $25,948,000 | -34.2% | 232,200 | -21.8% | 0.25% | -41.1% |
| Q3 2016 | $39,408,000 | +319.9% | 296,900 | +189.7% | 0.43% | +285.6% |
| Q2 2016 | $9,386,000 | +17.1% | 102,500 | -7.7% | 0.11% | -1.8% |
| Q1 2016 | $8,016,000 | +92.7% | 111,100 | +85.5% | 0.11% | +130.6% |
| Q4 2015 | $4,159,000 | +523.5% | 59,900 | +720.5% | 0.05% | +444.4% |
| Q3 2015 | $667,000 | -17.8% | 7,300 | +10.6% | 0.01% | -18.2% |
| Q2 2015 | $811,000 | +71.1% | 6,600 | +26.9% | 0.01% | +57.1% |
| Q1 2015 | $474,000 | +11.3% | 5,200 | -17.5% | 0.01% | +16.7% |
| Q4 2014 | $426,000 | -87.1% | 6,300 | -84.6% | 0.01% | -88.2% |
| Q3 2014 | $3,299,000 | -44.2% | 40,800 | -26.0% | 0.05% | -44.0% |
| Q2 2014 | $5,912,000 | +7022.9% | 55,100 | +3835.7% | 0.09% | +9000.0% |
| Q1 2014 | $83,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|